Evidence map›Paper›PMID 40377674›Full record

ArticleAnnals of hematology2025

Genetic polymorphism of novel SNP rs5006884 in OR51B6 and SNP rs4499252 in AHSP among transfusion-dependent and non-transfusion-dependent β-thalassemia/Hb E patients in Thailand: a multivariate analysis of clinical and genetic polymorphism.

Chidchanok Mahabhol, Lalana Yothindamrongkul, Nicha Nuntanajaroenkul, Purima Nawasod, Wanicha Tepakhan, Rossarin Karnpean, Panjarat Sowithayasakul, Nisa Makruasi, Therdkiat Trongwongsa, Wittaya Jomoui

Abstract read
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chidchanok MahabholFaculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Lalana YothindamrongkulFaculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Nicha NuntanajaroenkulFaculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Purima NawasodFaculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Wanicha TepakhanDepartment of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
Rossarin KarnpeanDepartment of Pathology, Faculty of Medicine, Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Ongkharak, Nakhon Nayok, Thailand.
Panjarat SowithayasakulResearch cluster in Hematology and genetic diseases, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Nisa MakruasiResearch cluster in Hematology and genetic diseases, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Therdkiat TrongwongsaDepartment of Pathology, Faculty of Medicine, Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Ongkharak, Nakhon Nayok, Thailand.
Wittaya JomouiDepartment of Pathology, Faculty of Medicine, Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Ongkharak, Nakhon Nayok, Thailand. wittayaj@g.swu.ac.th.

Funding

HRH Princess Maha Chakri Sirindhorn Medical Center, Faculty of Medicine, Srinakharinwirot University 093/2567
6 · The paper itself

Abstract

Compound heterozygous β-thalassemia and Hb E, a prevalent and severe form of thalassemia in Southeast Asia, manifests in two major clinical forms: transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT). This study investigates the association of genetic polymorphisms rs5006884 in OR51B6, rs4499252 in AHSP, rs9399137 in HBS1L-MYB, and rs4671393 in BCL11A with clinical severity and transfusion dependency in β-thalassemia/Hb E patients in Thailand. A total of 189 samples, including 58 TDT, 58 NTDT, 33 homozygous Hb E, and 40 wild-type individuals, were analyzed. Genotyping of the four single nucleotide polymorphisms (SNPs) was conducted using the rhAmp SNP Genotyping assay. Multivariate regression models were developed to evaluate the combined effects of genetic and clinical factors on transfusion dependency. The results showed that OR51B6 SNP rs5006884 TT genotype was significantly more frequent in the NTDT group (P < 0.05), suggesting a strong association with reduced transfusion dependency. Conversely, the AHSP SNP rs4499252 GG genotype was significantly less frequent in the homozygous Hb E group (P < 0.05) compared to other groups. Multivariate analyses highlighted hemoglobin (Hb) levels as a robust predictor of transfusion dependency, with specific HBB mutations including HBB:c.59 A > G, HBB:c.-78 A > G, HBB:c.316-197 C > T, and NC_000011.10:g.5224302_5227791del being significantly associated with NTDT (P < 0.05). Furthermore, rs5006884 in OR51B6 also played a significant role in NTDT in multivariate analyses. In contrast, SNPs in BCL11A (rs4671393), HBS1L-MYB (rs9399137), and AHSP (rs4499252) showed no significant independent associations with transfusion dependency or disease severity in this cohort. This study explores rs5006884 in OR51B6 and rs4499252 in AHSP in TDT and NTDT patients for the first time. These findings elucidate the interplay of genetic and clinical factors influencing β-thalassemia severity, paving the way for personalized management strategies to mitigate transfusion requirements.

Indexed as

beta-ThalassemiaBlood TransfusionHemoglobin EPolymorphism, Single NucleotideAdolescentAdultBlood ProteinsChildChild, PreschoolFemaleGenotypeHumansMaleMolecular ChaperonesMultivariate AnalysisRepressor ProteinsAHSP protein, humanBCL11A protein, humanBlood ProteinsHemoglobin EMolecular ChaperonesRepressor ProteinsBeta-thalassemiaBiomedicalHemoglobin EPolymorphismTransfusion dependent

Identifiers

PMID40377674
PMCPMC12141357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.